TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants
Clinical trial NCT00980538 · COMPLETED
Trial details
- NCT number
- NCT00980538
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-09
- Primary completion
- 2020-11-25
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.